Table 1.
Demographic and Behavioral Characteristics of Participants Screened for Hepatitis C (HCV)
| Variable | Number (Percent) | OR (95 % CI) for chronically infected compared to HCV negative | |
|---|---|---|---|
| HCV negative (N = 1,249) | Chronically infected participants (N = 36) | ||
| Male | 617 (49.4) | 29 (80.6) | 4.24 (1.84, 9.76) |
| African American | 1,139 (91.2) | 29 (80.6) | 0.40 (0.17, 0.93) |
| Single | 987 (79.0) | 27 (75.0) | 0.80 (0.37, 1.71) |
| Age | |||
| < 47 | 883 (71.0) | 8 (22.2) | REF |
| 47–67 | 338 (27.2) | 28 (77.8) | 10.24 (4.67, 22.45) |
| > 67 | 24 (1.8) | 0 (0.0) | — |
| Education | |||
| Less than high school | 200 (16.0) | 12 (33.3) | REF |
| High school degree/GED | 638 (51.1) | 18 (50.0) | 0.53 (0.25, 1.10) |
| At least some college | 411 (32.9) | 6 (16.7) | 0.29 (0.11, 0.74) |
| Income | |||
| Less than $10,000 | 456 (42.5) | 24 (72.7) | REF |
| $10,000–$14,999 | 194 (18.1) | 6 (18.2) | 0.69 (0.29, 1.64) |
| $15,000–$29,999 | 208 (19.4) | 2 (6.1) | 0.18 (0.04, 0.79) |
| > $30,000 | 214 (20.0) | 1 (3.0) | 0.18 (0.04, 0.77) |
| Self-identified sexual orientation | |||
| Heterosexual | 1,114 (89.7) | 35 (97.2) | REF |
| Gay/Lesbian | 58 (4.7) | 1 (2.8) | 0.51 (0.07, 3.78) |
| Bisexual | 70 (5.6) | 0 (0.0) | — |
| Ever incarcerated | 407 (32.7) | 26 (72.2) | 5.35 (2.55, 11.19) |
| Heavy episodic drinking | |||
| Never | 921 (74.0) | 17 (47.2) | REF |
| Less than monthly | 190 (15.3) | 5 (13.9) | 1.43 (0.52, 3.91) |
| Monthly | 59 (4.7) | 3 (8.3) | 2.75 (0.78, 9.67) |
| Weekly or more | 74 (6.0) | 11 (30.6) | 8.05 (3.64, 17.83) |
| Audit-C alcohol use disorder | 372 (29.8) | 21 (58.3) | 3.30 (1.68, 6.47) |
| Marijuana use ever | 729 (58.4) | 26 (72.2) | 1.85 (0.89, 3.88) |
| Cocaine/crack use ever | 184 (14.7) | 26 (72.2) | 15.05 (7.14, 31.73) |
| Heroin use ever | 25 (2.0) | 12 (33.3) | 24.5 (11.02, 54.38) |
| Prescription drug use ever | 97 (7.8) | 11 (30.6) | 5.22 (2.50, 10.94) |
| Other drug use ever | 56 (4.5) | 9 (25.0) | 7.10 (3.19, 15.81) |
| Alcohol use at last sex | 227 (18.4) | 17 (47.2) | 3.96 (2.03, 7.75) |
| Injection drug use | 11 (0.9) | 17 (47.2) | 100.21 (41.42, 242.43) |
Values in bold are significant at p < 0.05